Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Hepatocellular carcinoma is a cancer that starts in your liver. It's different from "secondary" liver cancers, which have spread to the liver from other organs. If caught early, it can sometimes ...

A key gene that fuels the molecular cascade driving prostate cancer bone metastasis progression may open avenues for targeted therapies. Laura is an assistant editor for The Scientist. She earned her ...

Unfortunately, even with the use of US contrast agents, there is considerable overlap in the appearance of metastases and hepatocellular carcinoma (HCC). [21] On a case-by-case basis, clinical and ...

A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of ...

Cancer becomes far more dangerous when it spreads beyond its original site. Some cancers stay in one place, while others ...

Bone metastases are cancers that have spread (metastasized) from other tissues in the body through the blood or lymphatic systems to the bone marrow. Bone metastases form the main type of bone ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

Hepatocellular carcinoma (HCC) represents about 80 to 90% of cases of primary liver cancer. On a global level, 905,700 new ...